Antifungal therapy, 1978.
The past 40 years have brought great advances in the knowledge of morphology, immunology and epidemiology of fungal infections in man. Each general advance in the science of medicine has had its counterpart in man's improved facility to deal with these infections therapeutically. Although satisfactory control of fungal infections of man is still lacking, productive paths of investigation seem to have been found and the continued application of rigorous discipline to research efforts should provide even more efficient treatment in the future.
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000266:history / Q000627:therapeutic use*; D001759:Blastomycosis / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005437:Flucytosine / Q000627:therapeutic use; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D009181:Mycoses / Q000188:drug therapy; D009761:Nystatin / Q000627:therapeutic use; D013266:Stilbamidines / Q000627:therapeutic use; D014481:United States
D000935:Antifungal Agents; D013266:Stilbamidines; D009761:Nystatin; D000666:Amphotericin B; D005437:Flucytosine